Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients

Hypertension

Volumn 44, Issue 1, 2004, Pages 48-54

  Okin, Peter M ^a   Devereux, Richard B ^a   Nieminen, Markku S ^b   Jern, Sverker ^c,e   Oikarinen, Lasse ^b   Viitasalo, Matti ^b   Toivonen, Lauri ^b   Kjeldsen, Sverre E ^d   Julius, Stevo ^c,e   Snapinn, Steven ^f   Dahlöf, Björn ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Coronary disease; Electrocardiography; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LOSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT DEPRESSION; STROKE; T WAVE; TREATMENT OUTCOME;

EID: 3042526351     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000132556.91792.6a     Document Type: Article

References (28)

1. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
2. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-759.
3. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391-1398.
4. Devereux RB, Reichek N. Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. J Electrocardiol. 1982;47-54.
5. Levy D, Labib SB, Andersen KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815-820.
6. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, Battistelli M, Bartoccini C, Porecellata C. Improved electrocardiographic diagnosis of echocardiographic left ventricular hypertrophy. Am J Cardiol. 1994;74:714-719.
7. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlöf B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: The LIFE Study. J Am Coll Cardiol. 2001;38:514-520.
8. Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV. Quantitative assessment of electrocardiographic left ventricular strain predicts increased left ventricular mass: The Strong Heart Study. J Am Coll Cardiol. 2002;40:1395-1400.
9. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation. 1961;33:697-713.
10. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 1998;31:383-390.
11. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med. 1969;71:89-105.
12. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1970;72:813-822.
13. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-1793.
14. Roman MJ, Kligfield P, Devereux RB, Niles NW, Hochreiter C, Halle A, Sato N, Borer JS. Geometric and functional correlates of electrocardiographic repolarization and voltage abnormalities in aortic regurgitation. J Am Coll Cardiol. 1987;9:500-508.
15. Sundström J, Lind L, Ärnlöv J, Zethelius B, Andrén B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103:2346-2351.
16. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
17. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE study group. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens. 1997;10:705-713.
18. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-423.
19. Norman JE, Levy D, Campbell G, Bailey JJ. Improved detection of echocardiographic left ventricular hypertrophy using a new electrocardiographic algorithm. J Am Coll Cardiol. 1993;21:1680-1686.
20. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, Devereux RB, Okin PM. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Hypertension. 2004;43:1029-1034.
21. Okin PM, Devereux RB, Palmieri V, Liu JE, Wachtell K, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Kjeldsen SE, Julius S, Dahlöf B. Regression of echocardiographic left ventricular hypertrophy in relation to resolution vs persistence of electrocardiographic strain after one-year of antihypertensive therapy: the LIFE Study. J Am Coll Cardiol. 2002;39:236A (abstract).
22. Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave. Eur Heart J. 2002;23:315-324.
23. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study. Hypertension. 2004;43:769-774.
24. Thiry PS, Rosenberg RM, Abbott JA. A mechanism for the electrocardiogram in response to left ventricular hypertrophy and acute ischemia. Circ Res. 1975;36:92-104.
25. Rembert JC, Kleinman LH, Fedor JM, Wechsler AS, Greenfield JC Jr. Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest. 1978;62:379-386.
26. O'Keefe JH, Owen RM, Bove AA. Influence of left ventricular mass on coronary artery cross-sectional area. Am J Cardiol. 1987;59:1395-1397.
27. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation. 2000;102:48-54.
28. Villari B, Hess OM, Meier C, Pucillo A, Gaglione A, Turina M, Krayenbuehl HP. Regression of coronary artery dimensions after successful aortic valve replacement. Circulation. 1992;85:972-978.